Gottlieb Recognizes OTC Monograph Woes During Confirmation Hearing

FDA commissioner nominee Scott Gottlieb agreed that the OTC drug monographs constitute “a system that is in need of modernization” during his April 5 confirmation hearing before the Senate HELP Committee. HELP Democrats tested the FDA commissioner nominee’s willingness to “stand up to the administration” and probed potential conflicts of interest.

FDA Commissioner nominee Scott Gottlieb says the OTC monograph program, a system the agency is looking at modernizing, needed “immediate action” 10 years ago before he left a commissioner’s office post.

More from Regulation

More from Policy & Regulation